nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Nausea—Valrubicin—urinary bladder cancer	0.00738	0.00738	CcSEcCtD
Dimenhydrinate—Fatigue—Mitomycin—urinary bladder cancer	0.00737	0.00737	CcSEcCtD
Dimenhydrinate—Dysuria—Thiotepa—urinary bladder cancer	0.00707	0.00707	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00705	0.00705	CcSEcCtD
Dimenhydrinate—Irritability—Fluorouracil—urinary bladder cancer	0.00691	0.00691	CcSEcCtD
Dimenhydrinate—Irritability—Cisplatin—urinary bladder cancer	0.00655	0.00655	CcSEcCtD
Dimenhydrinate—Neuritis—Epirubicin—urinary bladder cancer	0.0065	0.0065	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00629	0.00629	CcSEcCtD
Dimenhydrinate—Asthenia—Mitomycin—urinary bladder cancer	0.00614	0.00614	CcSEcCtD
Dimenhydrinate—Neuritis—Doxorubicin—urinary bladder cancer	0.00602	0.00602	CcSEcCtD
Dimenhydrinate—Diarrhoea—Mitomycin—urinary bladder cancer	0.00585	0.00585	CcSEcCtD
Dimenhydrinate—Sweating increased—Cisplatin—urinary bladder cancer	0.00578	0.00578	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00571	0.00571	CcSEcCtD
Dimenhydrinate—Dizziness—Mitomycin—urinary bladder cancer	0.00566	0.00566	CcSEcCtD
Dimenhydrinate—Tinnitus—Thiotepa—urinary bladder cancer	0.00565	0.00565	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00556	0.00556	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00547	0.00547	CcSEcCtD
Dimenhydrinate—Vomiting—Mitomycin—urinary bladder cancer	0.00544	0.00544	CcSEcCtD
Dimenhydrinate—Chills—Thiotepa—urinary bladder cancer	0.00543	0.00543	CcSEcCtD
Dimenhydrinate—Rash—Mitomycin—urinary bladder cancer	0.00539	0.00539	CcSEcCtD
Dimenhydrinate—Dermatitis—Mitomycin—urinary bladder cancer	0.00539	0.00539	CcSEcCtD
Dimenhydrinate—Headache—Mitomycin—urinary bladder cancer	0.00536	0.00536	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00529	0.00529	CcSEcCtD
Dimenhydrinate—Sweating increased—Etoposide—urinary bladder cancer	0.00529	0.00529	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00521	0.00521	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00518	0.00518	CcSEcCtD
Dimenhydrinate—Tension—Thiotepa—urinary bladder cancer	0.00517	0.00517	CcSEcCtD
Dimenhydrinate—Nervousness—Thiotepa—urinary bladder cancer	0.00512	0.00512	CcSEcCtD
Dimenhydrinate—Nausea—Mitomycin—urinary bladder cancer	0.00508	0.00508	CcSEcCtD
Dimenhydrinate—Vision blurred—Thiotepa—urinary bladder cancer	0.00497	0.00497	CcSEcCtD
Dimenhydrinate—Agitation—Thiotepa—urinary bladder cancer	0.00484	0.00484	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00475	0.00475	CcSEcCtD
Dimenhydrinate—Chills—Gemcitabine—urinary bladder cancer	0.00457	0.00457	CcSEcCtD
Dimenhydrinate—Convulsion—Thiotepa—urinary bladder cancer	0.00457	0.00457	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Etoposide—urinary bladder cancer	0.00452	0.00452	CcSEcCtD
Dimenhydrinate—Tinnitus—Cisplatin—urinary bladder cancer	0.00443	0.00443	CcSEcCtD
Dimenhydrinate—Confusional state—Thiotepa—urinary bladder cancer	0.00434	0.00434	CcSEcCtD
Dimenhydrinate—Photosensitivity—Methotrexate—urinary bladder cancer	0.00429	0.00429	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00421	0.00421	CcSEcCtD
Dimenhydrinate—Tachycardia—Thiotepa—urinary bladder cancer	0.0042	0.0042	CcSEcCtD
Dimenhydrinate—Vision blurred—Fluorouracil—urinary bladder cancer	0.00411	0.00411	CcSEcCtD
Dimenhydrinate—Anorexia—Thiotepa—urinary bladder cancer	0.0041	0.0041	CcSEcCtD
Dimenhydrinate—Photosensitivity—Epirubicin—urinary bladder cancer	0.00401	0.00401	CcSEcCtD
Dimenhydrinate—Chills—Etoposide—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Dimenhydrinate—Vision blurred—Cisplatin—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Dimenhydrinate—Tremor—Cisplatin—urinary bladder cancer	0.00387	0.00387	CcSEcCtD
Dimenhydrinate—Paraesthesia—Thiotepa—urinary bladder cancer	0.00386	0.00386	CcSEcCtD
Dimenhydrinate—Somnolence—Thiotepa—urinary bladder cancer	0.00382	0.00382	CcSEcCtD
Dimenhydrinate—Dyspepsia—Thiotepa—urinary bladder cancer	0.00379	0.00379	CcSEcCtD
Dimenhydrinate—Convulsion—Fluorouracil—urinary bladder cancer	0.00378	0.00378	CcSEcCtD
Dimenhydrinate—Decreased appetite—Thiotepa—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Dimenhydrinate—Fatigue—Thiotepa—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Dimenhydrinate—Constipation—Thiotepa—urinary bladder cancer	0.00368	0.00368	CcSEcCtD
Dimenhydrinate—Irritability—Methotrexate—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Dimenhydrinate—Confusional state—Fluorouracil—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Dimenhydrinate—Convulsion—Cisplatin—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Dimenhydrinate—Diplopia—Epirubicin—urinary bladder cancer	0.00352	0.00352	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.0035	0.0035	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Dimenhydrinate—Tachycardia—Fluorouracil—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Dimenhydrinate—Anorexia—Gemcitabine—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Dimenhydrinate—Urticaria—Thiotepa—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Dimenhydrinate—Vertigo—Etoposide—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Dimenhydrinate—Anorexia—Fluorouracil—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Dimenhydrinate—Hypotension—Gemcitabine—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Dimenhydrinate—Hypotension—Fluorouracil—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Dimenhydrinate—Tachycardia—Cisplatin—urinary bladder cancer	0.00329	0.00329	CcSEcCtD
Dimenhydrinate—Convulsion—Etoposide—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Dimenhydrinate—Insomnia—Gemcitabine—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—urinary bladder cancer	0.00326	0.00326	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00326	0.00326	CcSEcCtD
Dimenhydrinate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Dimenhydrinate—Insomnia—Fluorouracil—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Somnolence—Gemcitabine—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Anorexia—Cisplatin—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Dimenhydrinate—Somnolence—Fluorouracil—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Dimenhydrinate—Hypotension—Cisplatin—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Dimenhydrinate—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Dimenhydrinate—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Dimenhydrinate—Fatigue—Gemcitabine—urinary bladder cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Confusional state—Etoposide—urinary bladder cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Constipation—Gemcitabine—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Dimenhydrinate—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Dimenhydrinate—Asthenia—Thiotepa—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Dimenhydrinate—Dysuria—Methotrexate—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Dimenhydrinate—Paraesthesia—Cisplatin—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Tachycardia—Etoposide—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Dimenhydrinate—Anorexia—Etoposide—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Dimenhydrinate—Diarrhoea—Thiotepa—urinary bladder cancer	0.00294	0.00294	CcSEcCtD
Dimenhydrinate—Decreased appetite—Cisplatin—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Dimenhydrinate—Drowsiness—Methotrexate—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Dimenhydrinate—Hypotension—Etoposide—urinary bladder cancer	0.00289	0.00289	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Dimenhydrinate—Dizziness—Thiotepa—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Urticaria—Fluorouracil—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Dimenhydrinate—Paraesthesia—Etoposide—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Dimenhydrinate—Somnolence—Etoposide—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Dimenhydrinate—Vomiting—Thiotepa—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Dimenhydrinate—Rash—Thiotepa—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Dimenhydrinate—Dermatitis—Thiotepa—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Dimenhydrinate—Headache—Thiotepa—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Decreased appetite—Etoposide—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Fatigue—Etoposide—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Dimenhydrinate—Constipation—Etoposide—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Dimenhydrinate—Asthenia—Gemcitabine—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00257	0.00257	CcSEcCtD
Dimenhydrinate—Nausea—Thiotepa—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Etoposide—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Dimenhydrinate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Dimenhydrinate—Urticaria—Etoposide—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Dimenhydrinate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Dimenhydrinate—Tinnitus—Methotrexate—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Dimenhydrinate—Asthenia—Cisplatin—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Dizziness—Fluorouracil—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Dimenhydrinate—Chills—Methotrexate—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Dimenhydrinate—Diarrhoea—Cisplatin—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Dimenhydrinate—Vomiting—Gemcitabine—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Rash—Gemcitabine—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Dimenhydrinate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Dimenhydrinate—Headache—Gemcitabine—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Dimenhydrinate—Vomiting—Fluorouracil—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Rash—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Dermatitis—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Headache—Fluorouracil—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Dimenhydrinate—Asthenia—Etoposide—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Dimenhydrinate—Nausea—Gemcitabine—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Dimenhydrinate—Vomiting—Cisplatin—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Dimenhydrinate—Vision blurred—Methotrexate—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Dimenhydrinate—Rash—Cisplatin—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Dimenhydrinate—Dermatitis—Cisplatin—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Dimenhydrinate—Diarrhoea—Etoposide—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Dimenhydrinate—Nausea—Fluorouracil—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Dimenhydrinate—Dizziness—Etoposide—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Dimenhydrinate—Vertigo—Methotrexate—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Dimenhydrinate—Nausea—Cisplatin—urinary bladder cancer	0.002	0.002	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—urinary bladder cancer	0.002	0.002	CcSEcCtD
Dimenhydrinate—Convulsion—Methotrexate—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Vomiting—Etoposide—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Rash—Etoposide—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Dermatitis—Etoposide—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Headache—Etoposide—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Dimenhydrinate—Confusional state—Methotrexate—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Dimenhydrinate—Nausea—Etoposide—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Dimenhydrinate—Anorexia—Methotrexate—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Dimenhydrinate—Hypotension—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Dimenhydrinate—Insomnia—Methotrexate—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Dimenhydrinate—Paraesthesia—Methotrexate—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Dimenhydrinate—Somnolence—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Dimenhydrinate—Dyspepsia—Methotrexate—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Dimenhydrinate—Decreased appetite—Methotrexate—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Dimenhydrinate—Fatigue—Methotrexate—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Dimenhydrinate—Urticaria—Methotrexate—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Dimenhydrinate—Asthenia—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Dimenhydrinate—Diarrhoea—Methotrexate—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Dimenhydrinate—Dizziness—Methotrexate—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Dimenhydrinate—Vomiting—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Dimenhydrinate—Rash—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Dimenhydrinate—Dermatitis—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Dimenhydrinate—Headache—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Nausea—Methotrexate—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
